Using TCGA data and immune deconvolution methods, we found that all LUAD samples in the top tier of CCT4 expression had significantly greater Th2 cell infiltration than those with low CCT4, whereas key anti-tumor immune effectors (Th1 and CD8+ T cells) were less in many high-CCT4 tumors. The gene discussed is CD8A; the disease is neoplasm.